These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1890161

  • 1. A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman.
    Cama A, de la Luz Sierra M, Ottini L, Kadowaki T, Gorden P, Imperato-McGinley J, Taylor SI.
    J Clin Endocrinol Metab; 1991 Oct; 73(4):894-901. PubMed ID: 1890161
    [Abstract] [Full Text] [Related]

  • 2. Substitution of isoleucine for methionine at position 1153 in the beta-subunit of the human insulin receptor. A mutation that impairs receptor tyrosine kinase activity, receptor endocytosis, and insulin action.
    Cama A, Quon MJ, de la Luz Sierra M, Taylor SI.
    J Biol Chem; 1992 Apr 25; 267(12):8383-9. PubMed ID: 1314826
    [Abstract] [Full Text] [Related]

  • 3. Defect in tyrosine kinase activity of the insulin receptor from a patient with insulin resistance and acanthosis nigricans.
    Yamamoto R, Shiba T, Tobe K, Shibasaki Y, Koshio O, Izumi T, Odawara M, Mikami Y, Matsuura N, Akanuma Y.
    J Clin Endocrinol Metab; 1990 Apr 25; 70(4):869-78. PubMed ID: 2180980
    [Abstract] [Full Text] [Related]

  • 4. Insulin resistance and diabetes due to different mutations in the tyrosine kinase domain of both insulin receptor gene alleles.
    Kusari J, Takata Y, Hatada E, Freidenberg G, Kolterman O, Olefsky JM.
    J Biol Chem; 1991 Mar 15; 266(8):5260-7. PubMed ID: 2002058
    [Abstract] [Full Text] [Related]

  • 5. A mutation (Trp1193-->Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance.
    Iwanishi M, Haruta T, Takata Y, Ishibashi O, Sasaoka T, Egawa K, Imamura T, Naitou K, Itazu T, Kobayashi M.
    Diabetologia; 1993 May 15; 36(5):414-22. PubMed ID: 8390949
    [Abstract] [Full Text] [Related]

  • 6. Substitution of glutamic acid for alanine 1135 in the putative "catalytic loop" of the tyrosine kinase domain of the human insulin receptor. A mutation that impairs proteolytic processing into subunits and inhibits receptor tyrosine kinase activity.
    Cama A, de la Luz Sierra M, Quon MJ, Ottini L, Gorden P, Taylor SI.
    J Biol Chem; 1993 Apr 15; 268(11):8060-9. PubMed ID: 8096518
    [Abstract] [Full Text] [Related]

  • 7. A glycine-1008 to valine mutation in the insulin receptor in a woman with type A insulin resistance.
    Nozaki O, Suzuki Y, Shimada F, Hashimoto N, Taira M, Hatanaka Y, Notoya Y, Kanashiro O, Makino H, Yoshida S.
    J Clin Endocrinol Metab; 1993 Jul 15; 77(1):169-72. PubMed ID: 8392082
    [Abstract] [Full Text] [Related]

  • 8. Tyrosine-kinase defect of the insulin receptor in cultured fibroblasts from patients with lipoatropic diabetes.
    Magré J, Grigorescu F, Reynet C, Caron M, Capony JP, White MF, Picard J, Mirouze J, Capeau J.
    J Clin Endocrinol Metab; 1989 Jul 15; 69(1):142-50. PubMed ID: 2543688
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the insulin receptor gene tyrosine kinase domain in obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans (type C insulin resistance).
    Globerman H, Karnieli E.
    Int J Obes Relat Metab Disord; 1998 Apr 15; 22(4):349-53. PubMed ID: 9578241
    [Abstract] [Full Text] [Related]

  • 10. Functional properties of a naturally occurring Trp1200----Ser1200 mutation of the insulin receptor.
    Moller DE, Yokota A, Ginsberg-Fellner F, Flier JS.
    Mol Endocrinol; 1990 Aug 15; 4(8):1183-91. PubMed ID: 1963473
    [Abstract] [Full Text] [Related]

  • 11. Hybrid formation between endogenous mouse and transfected human tyrosine kinase-deficient (A/K1018) insulin receptors leads to decreased insulin sensitivity in 3T3-L1 adipocytes.
    Grako KA, McClain DA, Olefsky JM.
    Mol Endocrinol; 1994 Jun 15; 8(6):682-92. PubMed ID: 7935484
    [Abstract] [Full Text] [Related]

  • 12. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
    Blakesley VA, Kalebic T, Helman LJ, Stannard B, Faria TN, Roberts CT, LeRoith D.
    Endocrinology; 1996 Feb 15; 137(2):410-7. PubMed ID: 8593783
    [Abstract] [Full Text] [Related]

  • 13. Assessment of the in situ tyrosine kinase activity of mutant insulin receptors lacking tyrosine autophosphorylation sites 1162 and 1163.
    Yonezawa K, Roth RA.
    Mol Endocrinol; 1991 Feb 15; 5(2):194-200. PubMed ID: 1710030
    [Abstract] [Full Text] [Related]

  • 14. A 3-basepair in-frame deletion (delta Leu999) in exon 17 of the insulin receptor gene in a family with insulin resistance.
    Awata T, Matsumoto C, Momomura K, Takahashi Y, Odawara M, Kasuga M, Kadowaki T, Iwamoto Y.
    J Clin Endocrinol Metab; 1994 Dec 15; 79(6):1840-4. PubMed ID: 7989492
    [Abstract] [Full Text] [Related]

  • 15. Arg1201Gln mutation of insulin receptor impairs tyrosine kinase activity and causes insulin resistance: a case report.
    Ding Q, Liang M.
    Gynecol Endocrinol; 2020 Jun 15; 36(6):558-560. PubMed ID: 31899992
    [Abstract] [Full Text] [Related]

  • 16. NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene.
    Cocozza S, Porcellini A, Riccardi G, Monticelli A, Condorelli G, Ferrara A, Pianese L, Miele C, Capaldo B, Beguinot F.
    Diabetes; 1992 Apr 15; 41(4):521-6. PubMed ID: 1607076
    [Abstract] [Full Text] [Related]

  • 17. Insulin receptor tyrosine kinase activity is abnormal in circulating cells and cultured fibroblasts but normal in transformed lymphocytes from a type A insulin-resistant patient.
    Grunberger G, Comi RJ, Carpentier JL, Podskalny JM, McElduff A, Taylor SI, Gorden P.
    J Lab Clin Med; 1988 Jul 15; 112(1):122-32. PubMed ID: 3292678
    [Abstract] [Full Text] [Related]

  • 18. [Type C insulin resistance].
    Hashimoto N, Makino H.
    Nihon Rinsho; 1994 Oct 15; 52(10):2637-40. PubMed ID: 7983790
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K.
    Dan Med J; 2014 Jul 15; 61(7):B4890. PubMed ID: 25123125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.